Similarly, CDA1 inhibits the proliferation of HeLa cells [16], lung cancer cells (A549) [39], breast cancer cells (MCF-7) [39], and prostate cancer cells (LNCaP) [36], which is directly determined by its two cyclin-dependent kinase phosphorylation sites [16]. Here, TSPYL2 is linked to prostate carcinoma.